These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21285904)

  • 1. Nephrotoxicity--what do we know and what don't we know?
    Skinner R
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):128-34. PubMed ID: 21285904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic ifosfamide nephrotoxicity in children.
    Skinner R
    Med Pediatr Oncol; 2003 Sep; 41(3):190-7. PubMed ID: 12868118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children.
    Loebstein R; Atanackovic G; Bishai R; Wolpin J; Khattak S; Hashemi G; Gobrial M; Baruchel S; Ito S; Koren G
    J Clin Pharmacol; 1999 May; 39(5):454-61. PubMed ID: 10234592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance.
    Skinner R
    Pediatr Nephrol; 2018 Feb; 33(2):215-225. PubMed ID: 28434047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal complications of anti-cancer chemotherapy].
    Fillastre JP; Moulin B; Godin M; Josse S
    Pathol Biol (Paris); 1986 Nov; 34(9):1013-28. PubMed ID: 3543812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.
    Skinner R; Parry A; Price L; Cole M; Craft AW; Pearson AD
    Eur J Cancer; 2009 Dec; 45(18):3213-9. PubMed ID: 19850470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
    Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy.
    Perazella MA; Moeckel GW
    Semin Nephrol; 2010 Nov; 30(6):570-81. PubMed ID: 21146122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term evaluation of Ifosfamide-related nephrotoxicity in children.
    Oberlin O; Fawaz O; Rey A; Niaudet P; Ridola V; Orbach D; Bergeron C; Defachelles AS; Gentet JC; Schmitt C; Rubie H; Munzer M; Plantaz D; Deville A; Minard V; Corradini N; Leverger G; de Vathaire F
    J Clin Oncol; 2009 Nov; 27(32):5350-5. PubMed ID: 19826134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose.
    Skinner R; Parry A; Price L; Cole M; Craft AW; Pearson AD
    Pediatr Blood Cancer; 2010 Jul; 54(7):983-9. PubMed ID: 20405516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrotoxicity induced by chemotherapy].
    Di Vito R; Sirolli V; Amoroso L; Bonomini M
    G Ital Nefrol; 2011; 28(3):296-304. PubMed ID: 21626498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.
    Stöhr W; Paulides M; Bielack S; Jürgens H; Treuner J; Rossi R; Langer T; Beck JD
    Pediatr Blood Cancer; 2007 Apr; 48(4):447-52. PubMed ID: 16628552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onco-nephrology: renal toxicities of chemotherapeutic agents.
    Perazella MA
    Clin J Am Soc Nephrol; 2012 Oct; 7(10):1713-21. PubMed ID: 22879440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxicity of aminoglycosides and cephalosporins in combination.
    Rankin GO; Sutherland CH
    Adverse Drug React Acute Poisoning Rev; 1989; 8(2):73-88. PubMed ID: 2672726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for cisplatin-induced long-term nephrotoxicity in pediatric cancer survivors.
    Arga M; Oguz A; Pinarli FG; Karadeniz C; Citak EC; Emeksiz HC; Duran EA; Soylemezoglu O
    Pediatr Int; 2015 Jun; 57(3):406-13. PubMed ID: 25441241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to prevent nephrotoxicity of anticancer drugs.
    Skinner R
    Curr Opin Oncol; 1995 Jul; 7(4):310-5. PubMed ID: 7578377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticancer drug-induced nephrotoxicity].
    Isnard-Bagnis C; Moulin B; Launay-Vacher V; Izzedine H; Tostivint I; Deray G
    Nephrol Ther; 2005 May; 1(2):101-14. PubMed ID: 16895673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth impairment after ifosfamide-induced nephrotoxicity in children.
    Stöhr W; Patzer L; Paulides M; Kremers A; Beck JD; Langer T; Rossi R
    Pediatr Blood Cancer; 2007 May; 48(5):571-6. PubMed ID: 16755549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
    Launay-Vacher V; Rey JB; Isnard-Bagnis C; Deray G; Daouphars M;
    Cancer Chemother Pharmacol; 2008 May; 61(6):903-9. PubMed ID: 18317762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
    Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
    Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.